Demographic and clinical characteristics of prevention-eligible patients with migraine in the US: a linked national survey and administrative claims database study
| Autor: | Wenyu Ye, Karen Samaan, Dena H. Jaffe, Oksana Mason, John C. Rowland, Shonda A. Foster, Bridget L. Balkaran, M. Janelle Cambron-Mellott |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Receipt
medicine.medical_specialty business.industry Migraine Disorders Headache Database study General Medicine 030204 cardiovascular system & hematology medicine.disease Health Surveys United States Administrative claims 03 medical and health sciences Preventive therapy 0302 clinical medicine Migraine Family medicine Quality of Life Humans Medicine Female 030212 general & internal medicine business Retrospective Studies |
| DOI: | 10.6084/m9.figshare.13400327.v2 |
| Popis: | To characterize burden of migraine in prevention-eligible patients compared with prevention non-eligible patients in the United States (US). Receipt of preventive therapy was also examined among prevention-eligible patients. This retrospective study utilized data from the 2017 US National Health and Wellness Survey linked with medical and pharmacy claims. Patients aged ≥18 years who self-reported experiencing migraine and had confirmed evidence of migraine (≥1 medical or pharmacy claim) were included. Prevention eligibility was based on number of headache days in the past 30 days (prevention-eligible: ≥4 and prevention non-eligible: pp=.002) and activity days lost due to migraine (18.39 ± 28.08 vs. 10.69 ± 21.43, p=.015) than those not receiving preventive therapy. Prevention-eligible patients experience greater burden due to migraine, including more headache days, worse health-related quality-of-life, and greater work and activity impairment than prevention non-eligible patients. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|